MiNK Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold INKT, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
8
Funds holding
$238596
Total value held
Buying
7 added/new · 0 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $156435 | 13382 | +7179 | +115.73% |
| 2 | Ubs Group Ag | $57106 | 4885 | +4885 | NEW BUY |
| 3 | Us Bancorp \De\ | $23322 | 1995 | +1995 | NEW BUY |
| 4 | Morgan Stanley | $1321 | 113 | +9 | +8.65% |
| 5 | Barclays Plc | $281 | 24 | +24 | NEW BUY |
| 6 | Jpmorgan Chase & Co | $107 | 9 | — | Held |
| 7 | Wells Fargo & Company/Mn | $23 | 2 | +2 | NEW BUY |
| 8 | Amalgamated Financial Corp. | $1 | 295 | +295 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.